Cellular Oncology

Papers
(The median citation count of Cellular Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma169
Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells81
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer70
Retraction Note: Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications49
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy43
Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia42
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models41
O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency38
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway37
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells36
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis35
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway34
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing33
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy32
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy32
Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer31
Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis31
COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling30
Application of circulating tumour cells to predict response to treatment in head and neck cancer29
Chordoma cells possess bone-dissolving activity at the bone invasion front29
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer27
Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia27
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation26
Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients24
Unveiling therapeutic avenues targeting xCT in head and neck cancer23
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis22
Cell death in glioblastoma and the central nervous system21
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer21
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production21
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms21
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma21
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer20
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma19
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition19
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test18
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer18
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer18
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach18
Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma17
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling17
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma17
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression17
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer17
Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model16
Pathways and outputs orchestrated in tumor microenvironment cells by hypoxia-induced tumor-derived exosomes in pan-cancer16
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling16
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy16
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures16
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression16
Multi-dimensional characterization of apoptosis in the tumor microenvironment and therapeutic relevance in melanoma16
Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study15
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression15
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer15
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin15
The therapeutic potential of exosomes in lung cancer15
Correction to: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis15
Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor15
FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling15
Correction to: H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis14
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer14
Correction to: Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling14
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation13
STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma13
Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis13
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer13
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma13
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad1812
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma12
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion12
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis12
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities12
Methionine-producing tumor micro(be) environment fuels growth of solid tumors12
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution12
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma12
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer12
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway11
Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy11
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways11
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin11
Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study11
IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells11
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN111
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration11
SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma11
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis11
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma10
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma10
A comprehensive review of SHP2 and its role in cancer10
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex10
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation10
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis10
Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity10
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma10
FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination10
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing10
Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation10
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer10
Lactate score classification of hepatocellular carcinoma helps identify patients with tumors that respond to immune checkpoint blockade therapy10
Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution10
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma10
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p10
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer9
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming9
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis9
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies9
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)9
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma9
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia9
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia9
Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study9
Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors9
VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma9
Survivin degradation by bergenin overcomes pemetrexed resistance9
Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway8
NK cells as powerful therapeutic tool in cancer immunotherapy8
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells8
Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity8
Retraction Note: Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT28
Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer8
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK28
Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization8
Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway8
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue8
Retraction Note: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer8
Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer8
TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma8
Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis8
CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p8
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma8
Identification of a novel gene signature related to prognosis and metastasis in gastric cancer8
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN8
Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi8
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma8
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression8
Retraction Note to: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis8
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer8
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression8
PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA28
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers7
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression7
Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK7
Involvement of ACACA (acetyl-CoA carboxylase α) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts7
Integrating bulk and single-cell transcriptomics to elucidate the role and potential mechanisms of autophagy in aging tissue7
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder7
Glioblastoma, from disease understanding towards optimal cell-based in vitro models7
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer7
Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling7
USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination7
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma7
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer7
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy7
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects7
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma7
How VEGF-A and its splice variants affect breast cancer development – clinical implications7
Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance6
Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria6
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis6
Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report6
Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin6
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress6
Kavain ablates the radio-resistance of IDH-wildtype glioblastoma by targeting LITAF/NF-κB pathway6
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits6
Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi’s sarcoma-associated herpes virus6
Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma6
Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer6
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans6
BCAT1 contributes to the development of TKI-resistant CML6
Correction to: EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma6
Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma6
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis6
Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics6
3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment6
The emerging role of CARM1 in cancer5
TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner5
STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma5
Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ5
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening5
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma5
Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer5
HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells5
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism5
Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion5
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function5
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers5
IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling5
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options5
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer5
Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down5
Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features5
Tertiary lymphoid structures and their therapeutic implications in cancer5
TRIM28 promotes tumor growth and metastasis in breast cancer by targeting the BRD7 protein for ubiquitination and degradation5
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner5
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells5
DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer5
Correction to: 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment5
RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST5
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection5
Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein5
ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity5
Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer4
Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL34
Three-dimensional genome architecture in intrahepatic cholangiocarcinoma4
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer4
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment4
Targeting tumor associated macrophages (TAMs) reprograms tumor immune microenvironment to promote solid tumor immunotherapy4
Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation4
USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma4
The survival prediction analysis and preliminary study of the biological function of YEATS2 in hepatocellular carcinoma4
Spheroid-induced heterogeneity and plasticity of uveal melanoma cells4
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer4
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer4
Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch14
Evaluating the prognostic significance of tumor deposits in gastric cancer and strategies for their integration into the TNM staging system: a single-center retrospective study4
Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?4
Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma4
Toxicity profiles of immunochemotherapy for gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis4
Allelic expression imbalance of CDKN2A variants in childhood acute lymphoblastic leukemia4
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment4
Roles of NRF2 in DNA damage repair4
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models4
Research advances in the molecular classification of gastric cancer4
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells3
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer3
ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures3
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer3
Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer3
Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells3
The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis3
Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization3
Senolytics: charting a new course or enhancing existing anti-tumor therapies?3
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine3
Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells3
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration3
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC3
Feature-weight based measurement of cancerous transcriptome using cohort-wide and sample-specific information3
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer3
Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer3
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway3
Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux3
Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer3
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling3
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data3
BHLHE41, a transcriptional repressor involved in physiological processes and tumor development3
tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer3
Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling3
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells3
ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity3
CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells3
TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer3
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer3
0.063349962234497